American Tech Today
SEE OTHER BRANDS

Hottest science and technology news from the United States

American Tech Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Tech Today.

Press releases published on April 30, 2025

PathAI to Present at Digestive Disease Week

PathAI to Present at Digestive Disease Week

BOSTON, April 30, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in AI-powered pathology solutions, today announced it will present research from the outputs of IBD ExploreTM and AIM-HI UCTM at Digestive Disease Week (DDW) from May 3-6, 2025, in San …

Madhive Launches Maverick AI, the First Enterprise Intelligence Layer Built to Accelerate Media Sales and Drive Advertiser Outcomes

Madhive Launches Maverick AI, the First Enterprise Intelligence Layer Built to Accelerate Media Sales and Drive Advertiser Outcomes

NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- Madhive, the only unified operating system for local media, announced today the launch of Maverick AI, the first intelligence layer designed specifically to accelerate and optimize every step of an advertising …

Medicenna Presents Promising Preclinical Data from its First-in-Class Tumor Targeted and Conditionally Activated Anti-PD-1-IL-2 Bifunctional Superkine at the Annual 2025 AACR Meeting

Medicenna Presents Promising Preclinical Data from its First-in-Class Tumor Targeted and Conditionally Activated Anti-PD-1-IL-2 Bifunctional Superkine at the Annual 2025 AACR Meeting

MDNA113 is a novel IL-13Rα2 tumor-targeted and “masked” anti-PD-1-IL-2 Superkine (anti-PD1-IL-2SK), engineered to precisely deliver clinically validated anti-PD1 and IL-2SK to the tumor microenvironment (TME) IL-13Rα2 is overexpressed by some of the most “ …

VERSES® Announces Commercial Launch of Genius™

VERSES® Announces Commercial Launch of Genius™

VANCOUVER, British Columbia, April 30, 2025 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE:VERS) (OTCQB:VRSSF) ("VERSES'' or the "Company”) a cognitive computing company specializing in next-generation intelligent software systems is pleased to announce that the …

374Water Appoints James Pawloski as an Advisor to the Company

374Water Appoints James Pawloski as an Advisor to the Company

Former President …

Innventure to Present at Upcoming Innovation Conferences

Innventure to Present at Upcoming Innovation Conferences

ORLANDO, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- Innventure, Inc. (Nasdaq: INV), a technology commercialization platform, today announced that it will sponsor two conferences—the Front End of Innovation 2025 and the IRI Innovators Summit—that explore …

Lantheus Announces Alzheimer’s Disease Radiodiagnostic MK-6240 Meets Co-Primary Endpoints in Two Pivotal Studies

Lantheus Announces Alzheimer’s Disease Radiodiagnostic MK-6240 Meets Co-Primary Endpoints in Two Pivotal Studies

BEDFORD, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, …

Rakovina Therapeutics Inc. Announces 2024 Financial Results and Provides Corporate Update

Rakovina Therapeutics Inc. Announces 2024 Financial Results and Provides Corporate Update

VANCOUVER, British Columbia, April 30, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing next-generation cancer therapies through artificial intelligence (AI)-powered drug discovery announced …

Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study

Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study

— Successfully demonstrates strong tolerability, sustained drug release and safety SARASOTA, FL, April 30, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo,” or the “Company”), a developmental stage biopharmaceutical company focused on …

BioAtla to Participate in the Citizens Life Sciences Conference

BioAtla to Participate in the Citizens Life Sciences Conference

SAN DIEGO, April 30, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today …

Snyk Joins Coalition for Secure AI (CoSAI) to Champion Safe, Responsible AI Development

Snyk Joins Coalition for Secure AI (CoSAI) to Champion Safe, Responsible AI Development

Coalition signals Snyk’s commitment to advancing industry-wide collaboration around Secure-by-Design AI systems BOSTON, April 30, 2025 (GLOBE NEWSWIRE) -- Snyk, a leader in developer security, today announced it has joined the Coalition for Secure AI ( …

Integral Metals Reports Preliminary Geomicrobial Results from Burntwood Project, Highlights Biological Pathfinder Potential for REE Exploration

Integral Metals Reports Preliminary Geomicrobial Results from Burntwood Project, Highlights Biological Pathfinder Potential for REE Exploration

CALGARY, Alberta, April 30, 2025 (GLOBE NEWSWIRE) -- Integral Metals Corp. (CSE: INTG | OTC: ITGLF | FSE: ZK9) (the “Company” or “Integral”) is pleased to announce preliminary results from its 2024 geomicrobial survey at the Burntwood Project in northern …

Enterprises to Redefine Cyber Resilience with Rackspace and Rubrik

Enterprises to Redefine Cyber Resilience with Rackspace and Rubrik

SAN FRANCISCO, April 30, 2025 (GLOBE NEWSWIRE) -- LIVE! from RSAC, Rubrik (NYSE: RBRK), a leading cybersecurity company, and Rackspace Technology® (NASDAQ: RXT), a leading end-to-end hybrid cloud and AI solutions company, today announced a strategic …

Cidara Therapeutics to Participate in The Citizens Life Sciences Conference

Cidara Therapeutics to Participate in The Citizens Life Sciences Conference

SAN DIEGO, April 30, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced that company management will …

Concerns about Mental Health Medication Side Effects Remain a Barrier to Getting Help for Those Diagnosed with Depression and Anxiety, According to the GeneSight Mental Health Monitor

Concerns about Mental Health Medication Side Effects Remain a Barrier to Getting Help for Those Diagnosed with Depression and Anxiety, According to the GeneSight Mental Health Monitor

SALT LAKE CITY, April 30, 2025 (GLOBE NEWSWIRE) -- Nearly nine out of ten (89%) Americans diagnosed with depression and/or anxiety believe mental health medications are somewhat or very effective, yet concerns about potential side effects remain a …

Vertex Announces Strategic Investment in AI Tax Compliance Startup Kintsugi

Vertex Announces Strategic Investment in AI Tax Compliance Startup Kintsugi

KING OF PRUSSIA, Pa., April 30, 2025 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a global provider of indirect tax technology solutions, today announced it has completed a strategic investment in Kintsugi, a San Francisco- …

Global Uranium Advances Athabasca Basin Exploration with Launch of ZTEM Survey at Astro Project

Global Uranium Advances Athabasca Basin Exploration with Launch of ZTEM Survey at Astro Project

CALGARY, Alberta, April 30, 2025 (GLOBE NEWSWIRE) -- Global Uranium Corp. (CSE: GURN | OTC: GURFF | FRA: Q3J) (the "Company" or “Global”) and Cosa Resources Corp. (TSX-V: COSA) (OTCQB: COSAF) (FSE: SSKU) (“Cosa”) are pleased to announce that geophysical …

Vaxart Completes Enrollment in Phase 1 Trial for its Norovirus Oral Pill Vaccine Candidate

Vaxart Completes Enrollment in Phase 1 Trial for its Norovirus Oral Pill Vaccine Candidate

- Topline data expected in mid-2025 - SOUTH SAN FRANCISCO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that it completed enrollment of its Phase 1 clinical trial evaluating its second-generation oral norovirus …

electroCore to Announce First Quarter March 31, 2025 Financial Results on Wednesday, May 7, 2025

electroCore to Announce First Quarter March 31, 2025 Financial Results on Wednesday, May 7, 2025

ROCKAWAY, N.J., April 30, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic technology company, announced today that it will report financial results for the first quarter ended March 31, 2025, after the close of …

Actuate Therapeutics to Participate in Citizens Life Sciences Conference 2025

Actuate Therapeutics to Participate in Citizens Life Sciences Conference 2025

CHICAGO and FORT WORTH, Texas, April 30, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service